Detalles de la búsqueda
1.
Efficacy and predictors of immune checkpoint inhibitors in patients with gallbladder cancer.
Cancer Sci
; 115(6): 1979-1988, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38487949
2.
Impact of antithrombotic drugs on the accuracy of fecal occult blood testing for advanced colorectal neoplasia screening: a meta-analysis and systematic review.
Z Gastroenterol
; 61(3): 297-306, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35580620
3.
Prognosis of Advanced Cholangiocarcinoma in the Palliative Care Setting: A Series of 201 Cases.
Altern Ther Health Med
; 28(2): 24-31, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34653023
4.
Current and emerging immunotherapeutic approaches for biliary tract cancers.
Hepatobiliary Pancreat Dis Int
; 21(5): 440-449, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36115807
5.
Bortezomib in previously treated phosphatase and tension homology-deficient patients with advanced intrahepatic cholangiocarcinoma: An open-label, prospective and single-centre phase II trial.
Clin Transl Med
; 14(5): e1675, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38689424
6.
The pattern of tumor progression on first-line immune checkpoint inhibitor-based systemic therapy for Chinese advanced hepatocellular carcinoma -CLEAP 004 study.
Front Immunol
; 15: 1310239, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38711515
7.
Genomic and Immune Features in an Intrahepatic Cholangiocarcinoma Patient with Microsatellite Instability-High Suffered Rapid Acquired Resistance to PD-1 Inhibitor.
Liver Cancer
; 12(3): 281-288, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37593364
8.
Advanced renal pelvis carcinoma patient with an ERBB2 insertion mutation: a case report.
J Int Med Res
; 51(11): 3000605231204502, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37917812
9.
PTEN deficiency facilitates gemcitabine efficacy in cancer by modulating the phosphorylation of PP2Ac and DCK.
Sci Transl Med
; 15(704): eadd7464, 2023 07 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37437018
10.
Clinical and biomarker analyses of sintilimab plus gemcitabine and cisplatin as first-line treatment for patients with advanced biliary tract cancer.
Nat Commun
; 14(1): 1340, 2023 03 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36906670
11.
Expert Consensus on Pathological Diagnosis of Intrahepatic Cholangiocarcinoma (2022 version).
J Clin Transl Hepatol
; 11(7): 1553-1564, 2023 Dec 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38161496
12.
Immune-related RNA signature predicts outcome of PD-1 inhibitor-combined GEMCIS therapy in advanced intrahepatic cholangiocarcinoma.
Front Immunol
; 13: 943066, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36159865
13.
Polymorphisms of nuclear factor-κB family genes are associated with development of multiple myeloma and treatment outcome in patients receiving bortezomib-based regimens.
Haematologica
; 96(5): 729-37, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21228035
14.
PD-1 Inhibitors Plus Capecitabine as Maintenance Therapy for Advanced Intrahepatic Cholangiocarcinoma: A Case Report and Review of Literature.
Front Immunol
; 12: 799822, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-35003124
15.
A novel heterozygous mutation in the HMBS gene in a patient with acute intermittent porphyria and posterior reversible encephalopathy syndrome.
Mol Med Rep
; 22(1): 516-524, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32377710
16.
PTEN status determines chemosensitivity to proteasome inhibition in cholangiocarcinoma.
Sci Transl Med
; 12(562)2020 09 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-32967970
17.
Effects of knockout of lincRNA-p21 on the proliferation, migration and invasion ability of HepG2 liver cancer cells.
Oncol Lett
; 17(6): 5103-5107, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-31186722
18.
[Bortezomib-based combination therapy for relapsed or refractory multiple myeloma].
Zhonghua Nei Ke Za Zhi
; 47(2): 102-6, 2008 Feb.
Artículo
en Zh
| MEDLINE | ID: mdl-18683793
19.
Polymorphisms of CYP2C19 gene are associated with the efficacy of thalidomide based regimens in multiple myeloma.
Haematologica
; 92(9): 1246-9, 2007 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-17666363
20.
Prognostic factors and staging systems of multiple myeloma:.
Chin Med J (Engl)
; 120(19): 1655-8, 2007 Oct 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-17935664